|
A Comparative Operating Cost Analysis for
the Biotechnology Industry
This new 2012 report documents all geographically-variable operating costs scaled to a representative biotechnology research and development facility in 40 comparative U.S. and Canadian cities. Major benchmark locations of North America’s $100 billion biotechnology industry such as Boston, San Francisco, Silicon Valley, Philadelphia, Montgomery County, MD, North Carolina’s Research Triangle, New Jersey, Montreal, Indianapolis are all included as are a series of emerging regional centers of life sciences industry investment and jobs.
Price : $899
Listed Below Are the Cities Included in the 2012 Biotechnology BizCosts® Analysis:
- Phoenix, AZ
- Vancouver, BC
- Los Angeles/Long Beach, CA
- San Francisco, CA
- San Jose, CA
- Denver/Boulder, CO
- New Haven, CT
- Wilmington, DE
- Miami, FL
- Palm Beach County, FL
- Atlanta, GA
- Des Moines, IA
- Chicago, IL
- Indianapolis, IN
- Baltimore, MD
- Montgomery County, MD
- Boston, MA
- Ann Arbor, MI
- Kalamazoo, MI
- Minneapolis/St. Paul, MN
- Kansas City, MO
- St. Louis, MO
- Raleigh/Durham, NC
- Manchester, NH
- Newark/Northern, NJ
- Princeton/Central, NJ
- Rochester, NY
- Cleveland, OH
- Columbus, OH
- Toronto, ONT
- Portland, OR
- Philadelphia, PA
- Pittsburgh, PA
- Montreal, QUE
- Austin, TX
- Dallas/Ft. Worth, TX
- Houston, TX
- Salt Lake City, UT
- Seattle, WA
- Madison, WI
|
